Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katia Varani

Showing results (191-200 of 239) with videos related to

Pageof 24
Sort By:
Bioorganic & Medicinal Chemistry|November 11, 2008
Novel potent and highly selective human A(3) adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-c]quinoline series: molecular docking analysis and pharmacological studiesVittoria Colotta, Francesca Capelli, Ombretta Lenzi, et al.
Experimental Neurobiology|March 21, 2015
Amelioration of Cerebral Ischemic Injury by a Synthetic Seco-nucleoside LMT497Sangwoo Ryu, Joonha Kwon, Hyeon Park, et al.
Biochimica Et Biophysica Acta|March 17, 2009
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A(3) adenosine receptors in human renal cells: implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cellsGianluca Aguiari, Katia Varani, Marco Bogo, et al.
Molecules (Basel, Switzerland)|May 14, 2022
Pathophysiological Role and Medicinal Chemistry of A<sub>2A</sub> Adenosine Receptor Antagonists in Alzheimer's DiseaseStefania Merighi, Pier Andrea Borea, Katia Varani, et al.
Biochemical Pharmacology|October 13, 2005
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptorsKatia Varani, Stefania Gessi, Stefania Merighi, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A<sub>1</sub> Adenosine Receptor Positive Allosteric ModulatorsPaola Oliva, R Rama Suresh, Silvia Pasquini, et al.
European Journal of Medicinal Chemistry|August 6, 2013
Synthesis and biological effects of novel 2-amino-3-(4-chlorobenzoyl)-4-substituted thiophenes as allosteric enhancers of the A1 adenosine receptorRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Journal of Medicinal Chemistry|February 23, 2013
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluationLucia Squarcialupi, Vittoria Colotta, Daniela Catarzi, et al.
Journal of Medicinal Chemistry|March 18, 2015
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptorDelia Preti, Pier Giovanni Baraldi, Giulia Saponaro, et al.
Bioorganic & Medicinal Chemistry|November 14, 2008
Structure-activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A(3) adenosine receptor antagonistsPier Giovanni Baraldi, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.
Pageof 24

Showing results (191-200 of 239) with videos related to

Sort By:
Pageof 24
Bioorganic & Medicinal Chemistry|November 11, 2008
Novel potent and highly selective human A(3) adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-c]quinoline series: molecular docking analysis and pharmacological studiesVittoria Colotta, Francesca Capelli, Ombretta Lenzi, et al.
Experimental Neurobiology|March 21, 2015
Amelioration of Cerebral Ischemic Injury by a Synthetic Seco-nucleoside LMT497Sangwoo Ryu, Joonha Kwon, Hyeon Park, et al.
Biochimica Et Biophysica Acta|March 17, 2009
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A(3) adenosine receptors in human renal cells: implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cellsGianluca Aguiari, Katia Varani, Marco Bogo, et al.
Molecules (Basel, Switzerland)|May 14, 2022
Pathophysiological Role and Medicinal Chemistry of A<sub>2A</sub> Adenosine Receptor Antagonists in Alzheimer's DiseaseStefania Merighi, Pier Andrea Borea, Katia Varani, et al.
Biochemical Pharmacology|October 13, 2005
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptorsKatia Varani, Stefania Gessi, Stefania Merighi, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A<sub>1</sub> Adenosine Receptor Positive Allosteric ModulatorsPaola Oliva, R Rama Suresh, Silvia Pasquini, et al.
European Journal of Medicinal Chemistry|August 6, 2013
Synthesis and biological effects of novel 2-amino-3-(4-chlorobenzoyl)-4-substituted thiophenes as allosteric enhancers of the A1 adenosine receptorRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Journal of Medicinal Chemistry|February 23, 2013
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluationLucia Squarcialupi, Vittoria Colotta, Daniela Catarzi, et al.
Journal of Medicinal Chemistry|March 18, 2015
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptorDelia Preti, Pier Giovanni Baraldi, Giulia Saponaro, et al.
Bioorganic & Medicinal Chemistry|November 14, 2008
Structure-activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A(3) adenosine receptor antagonistsPier Giovanni Baraldi, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.
Pageof 24